Long-term adalimumab efficacy in patients with moderate-to-severe hidradenitis suppurativa/acne inversa: 3-year results of a phase 3 open-label extension study

CC Zouboulis, M M Okun, Errol Prens, R Gniadecki, PA Foley, C Lynde, J Weisman, YH Gu, DA Williams, GBE Jemec

Research output: Contribution to journalArticleAcademicpeer-review

99 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)60-+
JournalJournal of the American Academy of Dermatology
Issue number1
Publication statusPublished - 2019

Cite this